GI Dynamics Inc (GID) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
35
About the Report
About the Report
Summary
GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic surgery- without changing the anatomy. EndoBarrier is minimally invasive and completely reversible. It helps control glucose and facilitates weight loss in individuals who do not benefit from drugs and injections, for whom surgery is ruled out. GI Dynamics serves health care providers such as gastroenterologists, endocrinologists, and bariatric surgeons; and distributors of medical devices. The company markets its products through distributors in Australia, Europe, and the US. GI Dynamics is headquartered in Boston, Massachusetts, the US.
GI Dynamics Inc (GID)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
GI Dynamics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GI Dynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GI Dynamics Inc, Medical Devices Deals, 2012 to YTD 2018 9
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
GI Dynamics Raises USD0.7 Million in Security Purchase Plan of CDIs 11
GI Dynamics Raises USD1.2 Million in Private Placement of CDIs 12
GI Dynamics Completes Private Placement Of Chess Depository Interests For USD 31.2 Million 13
GI Dynamics Completes Second Tranche Of Private Placement Of Chess Depository Interests For USD 17.8 Million 14
GI Dynamics Completes Rights Offering Of Chess Depository Interests For USD 2.2 Million 15
Debt Offering 16
GI Dynamics Raises USD5 Million in Private Placement of 5% Notes 2018 16
GI Dynamics Inc-Key Competitors 17
GI Dynamics Inc-Key Employees 18
GI Dynamics Inc-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jul 31, 2018: GI Dynamics: Appendix 4C for the Quarter Ended 30 June 2018 20
Jan 31, 2017: GI Dynamics: Quarterly Report-Quarter Ended 31 December 2016 21
Corporate Communications 22
Nov 23, 2017: GI Dynamics Announces Change to Board of Directors 22
Aug 23, 2017: GI Dynamics Appoints Juliet Thompson to Company's Board of Directors 23
Aug 13, 2017: GI Dynamics Welcomes New Members to its Scientific Advisory Board 24
Jun 19, 2017: GI Dynamics Announces Additional Members to Its Scientific Advisory Board 25
Jun 02, 2017: GI Dynamics Announces Change to Board of Directors 26
May 08, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier 27
Mar 13, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier 28
Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company's Board of Directors 29
Other Significant Developments 30
Jan 15, 2018: GI Dynamics Provides 2017 Review and 2018 Business Outlook 30
Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Figure
List of Figures
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GI Dynamics Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
GI Dynamics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GI Dynamics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GI Dynamics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
GI Dynamics Inc, Medical Devices Deals, 2012 to YTD 2018 9
GI Dynamics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GI Dynamics Raises USD0.7 Million in Security Purchase Plan of CDIs 11
GI Dynamics Raises USD1.2 Million in Private Placement of CDIs 12
GI Dynamics Completes Private Placement Of Chess Depository Interests For USD 31.2 Million 13
GI Dynamics Completes Second Tranche Of Private Placement Of Chess Depository Interests For USD 17.8 Million 14
GI Dynamics Completes Rights Offering Of Chess Depository Interests For USD 2.2 Million 15
GI Dynamics Raises USD5 Million in Private Placement of 5% Notes 2018 16
GI Dynamics Inc, Key Competitors 17
GI Dynamics Inc, Key Employees 18
GI Dynamics Inc, Other Locations 19
Why Buy From US?
![RRR](images/data-analysis.webp)
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
![reach](images/social-reach.webp)
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
![Research](images/monitoring.webp)
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
![Insite](images/insight.webp)
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
![Trust](images/guarantee.webp)
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
![support](images/customer-care.webp)
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.